When medical infusion treatments become a mainstream treatment, will they have an impact?

This is an excerpt from Next BigFuture’s forthcoming book, Doctors Are Now Doctors.

The book examines the medical treatment of dermatillomanias, a group of conditions where a person’s skin turns a deep blue, and where doctors can inject drugs or other treatments to treat the condition.

Dermatillomans can be very distressing, with symptoms that can range from the mildest to the severe, and the treatments can range in effectiveness.

For people with dermatillomias, their treatment options may be limited.

Dermal transplantation, a type of treatment for skin cancer, involves inserting an artificial skin cell into the patient’s body, but it can lead to severe side effects.

And in 2015, scientists announced a breakthrough in the treatment of psoriasis: a new treatment called “solar phototherapy” that uses light to stimulate the skin cells and remove the abnormal pigmentation on the surface of the skin.

This type of phototherapy is typically used to treat psorias that affect the skin’s outer layer of cells, but the new study suggests it could be used to help patients with dermatilomias.

“The results show that in many patients with psoriosa, phototherapy can result in substantial improvement in the quality of life, but that it also requires a large investment in specialized equipment and equipment maintenance, which may not be financially viable for many people,” lead author Dr. Tariq Rafiq told Next Big Futures.

“This makes it even more important that dermatilloma patients receive treatment, preferably with phototherapy.”

The new study, published in the journal PLoS ONE, also shows that the treatment has a high success rate.

Patients with psorbosis were significantly better off after a phototherapy treatment than before.

The treatment can significantly reduce the size of the pores in the skin, allowing the cells to grow in the area without scarring.

“It seems that phototherapy offers a way to increase the number of healthy, healthy cells in the surface layer of the epidermis without damaging the epoxy layer of skin,” lead researcher Dr. John C. O’Connell, professor of dermatology at the University of Chicago, told Next Bi.

“That may be a promising strategy for reducing the growth of these cells that are potentially damaging to the skin.”

O’Donnell and his colleagues hope that photovoltaic treatments will become a more common treatment for dermatilloms and other conditions that require treatment.

“As the technology advances, we may see dermatillomas become a common skin condition, particularly in areas where the surface area of skin is too small for the cells that generate the skin,” O’Neill told Next Future.

“I would be surprised if we didn’t see the photovollective phototherapy approach as a viable alternative for these people.”

Follow Next Big Tomorrow on Facebook, Twitter, and Instagram.